Novo Nordisk rapped by advertising regulator after £7.8m irregular payments
The pharmaceutical giant admitted failing to disclose the payments from 2020-2022 which had been “incorrectly categorised in finance systems as a result of human error”.
The pharmaceutical giant admitted failing to disclose the payments from 2020-2022 which had been “incorrectly categorised in finance systems as a result of human error”.